烧伤后瘙痒的治疗路径与长期患病率:基于真实世界数据的观察性研究
本研究利用TriNetX真实世界数据库回顾性分析257,360例烧伤患者,按烧伤总面积分层。烧伤后瘙痒患病率在儿童为3.29%–7.95%,成人为1.50%–9.75%,以20–39% TBSA、41–60岁及伤后3年内最高。最常用药物为H1抗组胺药、5-HT3受体拮抗剂和神经病理性疼痛药物,治疗模式不一致。
要点
- 烧伤后瘙痒患病率随年龄增长呈下降趋势,但随时间推移呈上升趋势。
- 中度烧伤(20–39% TBSA)患者瘙痒患病率最高,峰值在伤后3年内。
- 严重嗜酸性粒细胞增多在>40% TBSA的41–60岁患者中达峰值。
核心结论
- 烧伤后瘙痒患病率因年龄和烧伤面积而异,随年龄增长呈下降趋势但随时间推移呈上升趋势。
- 中度烧伤(20–39% TBSA)患者患病率最高。
- 治疗模式不一致,需标准化和循证策略。
研究设计与样本
- 回顾性队列研究,使用真实世界数据库TriNetX。
- 纳入257,360例烧伤患者,平均年龄37±23岁。
- 按TBSA分为三组:<20%(轻度)、20–39%(中度)、≥40%(重度)。
- 评估瘙痒患病率、嗜酸性粒细胞增多状态和治疗模式,采用卡方检验分析年龄组和时间效应。
主要发现
- 瘙痒患病率在儿童为3.29%–7.95%,成人为1.50%–9.75%。
- 患病率峰值见于20–39% TBSA、41–60岁及伤后3年内。
- 严重嗜酸性粒细胞增多在>40% TBSA的41–60岁患者中达峰值。
- 所有队列最常用药物类别为H1抗组胺药、5-HT3受体拮抗剂和神经病理性疼痛药物。
临床怎么用
- 临床应关注中度烧伤(20–39% TBSA)、41–60岁及伤后3年内的患者瘙痒风险。
- 常用药物包括H1抗组胺药、5-HT3受体拮抗剂和神经病理性疼痛药物,但需注意治疗模式不一致。
- 建议推动标准化和循证的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Burns heal with long-lasting scars and complications, such as persistent pruritus. To date, there is no consensus on optimal treatment. This study aims to identify prevalence and treatment patterns of burn-related pruritus using a large dataset. METHODS: A retrospective cohort study was conducted using the real-world database TriNetX. Burn patients were identified and stratified into three cohorts by extent of total body surface area (TBSA) burned: Cohort 1 (<20 %; mild), Cohort 2 (20-39 %; moderate), and Cohort 3 (≥40 %; severe). Prevalence of pruritus, eosinophilia status, and treatment patterns were assessed. Age group and temporal effects were tested using Chi-square. RESULTS: We identified 257,360 burn patients with a mean age of 37 ± 23 years. Pruritus prevalence ranged from 3.29 % to 7.95 % in paediatric patients and from 1.50 % to 9.75 % in adult patients. Peak prevalence occurred in those with 20-39 % TBSA burned, aged 41-60 years, and within 3 years after burn. Severe eosinophilia peaked in 41-60-year-olds with burns > 40 % of TBSA. The most commonly prescribed drug classes across all cohorts were H1-antihistamines, 5-HT3 receptor antagonists, and neuropathic pain drugs. CONCLUSION: Our real-world database analysis indicates that the prevalence of post-burn pruritus varies by age and burn size, showing a tendency to decrease with age but increase over time. The highest prevalence was observed in patients with moderate-sized burns (20-39 % TBSA burned). Treatment patterns remain inconsistent, underscoring the need for standardized and evidence-based strategies.
引用
- Kleinhapl J, Danielski LG, Ekale JN, et al. Analysis of treatment pathways and long-term prevalence of pruritus after burn - An observational study with real-world data. Burns. 2026. PMID: 41707540. doi:10.1016/j.burns.2026.107894
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。